A metropolitan toxicology service is evaluating several patients with suspected substance use disorders. Correlate the following distinct clinical manifestations with their correct underlying etiology.
- Rotatory nystagmus, impulsivity, ataxia, and diminished pain perception resulting in combative behavior.Phencyclidine (PCP) intoxication
- Severe dysphoria, vivid and unpleasant dreams, hypersomnolence, increased appetite, and psychomotor retardation.Cocaine withdrawal
- Diaphoresis, bruxism, hyperthermia, and confusion complicated by new-onset generalized seizures and hyponatremia.MDMA (Ecstasy) intoxication
- Mydriasis, piloerection, rhinorrhea, excessive yawning, and diffuse myalgias in an alert and highly distressed patient.Opioid withdrawal
- Global confusion, prominent visual hallucinations, resting tremor, and autonomic hyperactivity peaking on hospital day 3.Severe alcohol withdrawal
Answer
Phencyclidine (PCP) intoxication matches rotatory nystagmus and combativeness. Cocaine withdrawal matches hypersomnolence, hyperphagia, and vivid dreams. MDMA intoxication matches bruxism, hyperthermia, and hyponatremia. Opioid withdrawal matches piloerection, yawning, and myalgias. Severe alcohol withdrawal matches day 3 delirium and autonomic hyperactivity.
Each substance toxidrome has distinct hallmark features. PCP involves nystagmus and analgesia; cocaine withdrawal involves a depressive 'crash' with hyperphagia and hypersomnolence; MDMA toxicity uniquely causes bruxism and SIADH leading to hyponatremia; opioid withdrawal presents with yawning, piloerection, and myalgias with an intact sensorium; and severe alcohol withdrawal (delirium tremens) features late-onset confusion, hallucinations, and autonomic hyperactivity.
Step-by-Step Solution
Key Concept
Differentiation of substance-induced toxidromes and withdrawal syndromes based on unique physical exam findings, such as nystagmus in PCP, hyponatremia in MDMA, and piloerection in opioid withdrawal.